Location History:
- Croydon, GB (1986 - 1990)
- Beckenham, Kent, GB (1997)
- Beckenham, GB (1992 - 1998)
Company Filing History:
5 out of 521 
5 out of 281 
2 out of 832,891 Years Active: 1986-1998
Title: The Innovative Contributions of Richard M Hyde
Introduction
Richard M Hyde is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target central nervous system disorders. With a total of 12 patents to his name, Hyde's work has had a profound impact on medical science.
Latest Patents
Hyde's latest patents include the development of 2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidines. This class of substituted phenylpyrimidine compounds has been identified as potent inhibitors of the excitatory amino acid, glutamate. Such compounds are particularly useful in the treatment or prevention of various CNS disorders, including cerebral ischaemic damage and epilepsy. Additionally, he has worked on pharmacologically active CNS compounds that share similar therapeutic applications.
Career Highlights
Throughout his career, Hyde has been associated with prominent companies in the pharmaceutical industry, including Burroughs Wellcome Co. and Glaxo Wellcome Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development in the field of CNS pharmacology.
Collaborations
Hyde has collaborated with esteemed colleagues such as Alistair A Miller and Malcolm Stuart Nobbs. These partnerships have further enhanced his research capabilities and have led to innovative solutions in the treatment of CNS disorders.
Conclusion
Richard M Hyde's contributions to pharmacology and his innovative patents have significantly advanced the understanding and treatment of central nervous system disorders. His work continues to inspire future research in this vital area of medicine.